1st RSV vaccine could be approved by August, pending FDA review
Pfizer’s vaccine would be the first RSV vaccine given to pregnant people to protect infants. The company said that there were “no safety concerns” for vaccinated pregnant participants and their newborns during the trial.
Read MoreABC7 RSS Feed